Drug: SERETIDE Injury: Condition aggravated Quarter: 2016Q3
Total Records: 9 Number of Pages: 1
Event ID | DRUGNAME | PT | Drug Manufacturer | Patient Age | Sex | Weight | Date (YYYYMMDD) | Country |
---|---|---|---|---|---|---|---|---|
124734542 | SERETIDE | Condition aggravated | GLAXOSMITHKLINE | 0.00 | F | 0 | 20160727 | CN |
125226411 | SERETIDE | Condition aggravated | GLAXOSMITHKLINE | 58.29 YR | F | 44 KG | 20160701 | VE |
125449101 | SERETIDE | Condition aggravated | GLAXOSMITHKLINE | 92.68 YR | F | 0 | 20160711 | PE |
126063971 | SERETIDE | Condition aggravated | GLAXOSMITHKLINE | 0.00 | M | 0 | 20160729 | GB |
126409191 | SERETIDE | Condition aggravated | GLAXOSMITHKLINE | 56.18 YR | F | 0 | 20160810 | PE |
126441561 | SERETIDE | Condition aggravated | GLAXOSMITHKLINE | 0.00 | F | 0 | 20160811 | CN |
126456873 | SERETIDE | Condition aggravated | GLAXOSMITHKLINE | 0.00 | M | 0 | 20160826 | CN |
126480461 | SERETIDE | Condition aggravated | GLAXOSMITHKLINE | 77.32 YR | F | 0 | 20160812 | PE |
127045141 | SERETIDE | Condition aggravated | GLAXOSMITHKLINE | 89.82 YR | F | 0 | 20160831 | BR |
Total Records: 9 Number of Pages: 1